Drugs / autologous adipose cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02529865 | Jul 2015 → Mar 2019 | female stress incontinence | Nagoya University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | autologous adipose cells | “1 mL of the isolated ADRC is injected into the region of the external urethral sphincter, and another 4 mL of the ADRC and 16mL autologous adipose cells is injected under the...” NCT02529865 ↗ |
| Modality | Cell therapy | “16mL autologous adipose cells” NCT02529865 ↗ |
| Route | Other | “16mL autologous adipose cells is injected under the urethral mucosa” NCT02529865 ↗ |